Pharmaceutical giant Glenmark on Wednesday said its Phase-3 clinical trials of antiviral drug Favipiravir showed improvement in mild and moderate novel coronavirus patients. In a statement on Wednesday, Glemnmark said Covid-19 patients administered with Favipiravir reported faster clinical cure and viral clearance as compared to those with routine care.
Featured Post
Hindenburg Crashes without any cogent reason
TODAY'S ECONOMICS once again proved correct Esteemed readers will recollect that earlier TODAY'S ECONOMICS had in its editorial (D...
-
By Deepika Bhardwaj Also called FGM (Female Genital Mutilation) is the practice of excising the clitoris and labia of a girl or woman and s...
-
The Hindenburg report, released on 24th Jan, 2023 had the intended outcome. The short seller shaved off $ 100 Billion Dollars or more of Ada...
No comments:
Post a Comment